MedDay announces its pivotal Phase III study of MD1003 in patients with Progressive Multiple Sclerosis meets primary endpoint
Plenty to feed on as stocks keep 'grinding higher'
UPDATE: How to make sense of this 'buy the dips, grind higher stock market
Changes in Aerocrine’s Executive Leadership Team
Research and Markets: 100 R&D Intensive Medical Devices/Technology/Supplies Companies 2015
The most and least expensive places around the world
UPDATE: Why not to buy an iPhone in Rio: a jet-setter's guide
AAK: Conference Call for Investors, Stock Market Analysts and Media – Release of AAK’s Interim Report for the First Quarter 2015